Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 462 participants.

Also called NCT05892510

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 462 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05892510
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05892510. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2027-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Condition
Ischemic Stroke, Acute
Condition
Cerebrovascular Disorders
Condition
Brain Disorder
Condition
Central Nervous System Diseases
Intervention (Drug)
Intra-arterial tenecteplase injection at the completion of thrombectomy
Intervention (Drug)
Placebo
Lead sponsor
University of Melbourne (class: other)

Record details

Record id
cardio:ct-nct05892510
Content hash
5df5f2b1b53032cd544395e8dfd464313316a4b62fc4c582f5aefdc478494022